greenTEG AG offers to sponsor Covid-19 research with its unique fever-monitor

The current COVID-19 global pandemic raises many challenges for individuals, companies, and governments. As the disease has spread to well nearly 200 countries, the devastating health and socio-economic impact of the pandemic becomes evident. Consequently, these developments have sparked wide-scale initiatives by companies and individuals to develop new tools like vaccines, protective equipment, or monitoring solutions to assist in the battle of this unexpected crisis.

Fever is the most common initial symptom[1] of the virus and this is where greenTEG wants to help. Our non-invasive and continuous core body temperature monitoring patch enables early fever detection using only skin contact. The accuracy of the device has been verified in multiple clinical studies.

We believe that our solution can reduce the strain on the healthcare system by monitoring healthcare professionals exposed to the virus and by furthermore monitoring general ward patients, thus freeing up precious nursing resources. The device can further be effective for scientists researching the influence of the novel Coronavirus on the body temperature (e.g. temperature patterns).

greenTEG is offering its expertise and its technology as a contribution to overcome the current Corona crisis faster and with less sacrifice. greenTEG is willing to sponsor sensors for selected medical research on Covid-19 patients or health care workers. At the same time greenTEG is looking for partners capable of bringing its continuous and non-invasive core body temperature monitoring solution to the market as quickly as possible.  Interested researchers or clinicians as well as potential commercialization partners, please contact us at hendrichs@greenteg.com

You can dowload the press note in English clicking here.

For the French press note, please follow this link.

For the German version of the press release, click here.


[1] 98.6% of patients showed fever at onset of a diagnosed Covid-19 infection according to Wang D, 07.02.2020: Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia

More news

Wireless sensor network for estimating building performance

Read more

Interview at Venturelab: greenTEG and the COVID-19 crisis

Read more

TeleTop interviewed Wulf Glatz (CEO, greenTEG AG) on COVID-19 and how the gSKIN® Fever Temp Patch can help solving our current pandemic

Read more

greenTEG AG offers to sponsor Covid-19 research with its unique fever-monitor

Read more

In Operando Calorimetric Measurements for Electrochemical Capacitors

Read more

COVID-19 ¦ greenTEG global preparedness

Read more

Using gSKIN® heat flux sensors for the calorimetric measurement of batteries

Read more

A heat flux sensor test setup

Read more
Read all